128 related articles for article (PubMed ID: 28115060)
1. Molecular and metabolic features of oncocytomas: Seeking the blueprints of indolent cancers.
De Luise M; Girolimetti G; Okere B; Porcelli AM; Kurelac I; Gasparre G
Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):591-601. PubMed ID: 28115060
[TBL] [Abstract][Full Text] [Related]
2. Mitochondria and cancer chemoresistance.
Guerra F; Arbini AA; Moro L
Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):686-699. PubMed ID: 28161329
[TBL] [Abstract][Full Text] [Related]
3. Dysregulation of mitophagy in carcinogenesis and tumor progression.
Chang JY; Yi HS; Kim HW; Shong M
Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):633-640. PubMed ID: 28017650
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of mitochondrial biogenesis and paradoxical inhibition of lactate dehydrogenase mediated by 14-3-3η in oncocytomas.
Feng J; Zhang Q; Li C; Zhou Y; Zhao S; Hong L; Song Q; Yu S; Hu C; Wang H; Mao C; Shepard MJ; Hao S; Dominah G; Sun M; Wan H; Park DM; Gilbert MR; Xu G; Zhuang Z; Zhang Y
J Pathol; 2018 Jul; 245(3):361-372. PubMed ID: 29704241
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial metabolism and energy sensing in tumor progression.
Iommarini L; Ghelli A; Gasparre G; Porcelli AM
Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):582-590. PubMed ID: 28213331
[TBL] [Abstract][Full Text] [Related]
6. Metabolic synthetic lethality in cancer therapy.
Zecchini V; Frezza C
Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):723-731. PubMed ID: 27956047
[TBL] [Abstract][Full Text] [Related]
7. VDAC in cancer.
Mazure NM
Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):665-673. PubMed ID: 28283400
[TBL] [Abstract][Full Text] [Related]
8. Energy metabolism in skin cancers: A therapeutic perspective.
Hosseini M; Kasraian Z; Rezvani HR
Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):712-722. PubMed ID: 28161328
[TBL] [Abstract][Full Text] [Related]
9. Respiratory chain complex I is a mitochondrial tumor suppressor of oncocytic tumors.
Zimmermann FA; Mayr JA; Feichtinger R; Neureiter D; Lechner R; Koegler C; Ratschek M; Rusmir H; Sargsyan K; Sperl W; Kofler B
Front Biosci (Elite Ed); 2011 Jan; 3(1):315-25. PubMed ID: 21196312
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial dysfunction and mitochondrial dynamics-The cancer connection.
Srinivasan S; Guha M; Kashina A; Avadhani NG
Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):602-614. PubMed ID: 28104365
[TBL] [Abstract][Full Text] [Related]
11. Learning from oncocytic tumors: Why choose inefficient mitochondria?
Gasparre G; Romeo G; Rugolo M; Porcelli AM
Biochim Biophys Acta; 2011 Jun; 1807(6):633-42. PubMed ID: 20732299
[TBL] [Abstract][Full Text] [Related]
12. Etiopathogenesis of oncocytomas.
Correia M; Pinheiro P; Batista R; Soares P; Sobrinho-Simões M; Máximo V
Semin Cancer Biol; 2017 Dec; 47():82-94. PubMed ID: 28687249
[TBL] [Abstract][Full Text] [Related]
13. Defective oxidative phosphorylation in thyroid oncocytic carcinoma is associated with pathogenic mitochondrial DNA mutations affecting complexes I and III.
Bonora E; Porcelli AM; Gasparre G; Biondi A; Ghelli A; Carelli V; Baracca A; Tallini G; Martinuzzi A; Lenaz G; Rugolo M; Romeo G
Cancer Res; 2006 Jun; 66(12):6087-96. PubMed ID: 16778181
[TBL] [Abstract][Full Text] [Related]
14. Expression and putative role of mitochondrial transport proteins in cancer.
Lytovchenko O; Kunji ERS
Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):641-654. PubMed ID: 28342810
[TBL] [Abstract][Full Text] [Related]
15. NO control of mitochondrial function in normal and transformed cells.
Tengan CH; Moraes CT
Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):573-581. PubMed ID: 28216426
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial uncoupling in cancer cells: Liabilities and opportunities.
Baffy G
Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):655-664. PubMed ID: 28088333
[TBL] [Abstract][Full Text] [Related]
17. Clonal expansion of mutated mitochondrial DNA is associated with tumor formation and complex I deficiency in the benign renal oncocytoma.
Gasparre G; Hervouet E; de Laplanche E; Demont J; Pennisi LF; Colombel M; Mège-Lechevallier F; Scoazec JY; Bonora E; Smeets R; Smeitink J; Lazar V; Lespinasse J; Giraud S; Godinot C; Romeo G; Simonnet H
Hum Mol Genet; 2008 Apr; 17(7):986-95. PubMed ID: 18156159
[TBL] [Abstract][Full Text] [Related]
18. Drug discovery strategies in the field of tumor energy metabolism: Limitations by metabolic flexibility and metabolic resistance to chemotherapy.
Amoedo ND; Obre E; Rossignol R
Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):674-685. PubMed ID: 28213330
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial dynamics protein Drp1 is overexpressed in oncocytic thyroid tumors and regulates cancer cell migration.
Ferreira-da-Silva A; Valacca C; Rios E; Pópulo H; Soares P; Sobrinho-Simões M; Scorrano L; Máximo V; Campello S
PLoS One; 2015; 10(3):e0122308. PubMed ID: 25822260
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial complex I is deficient in renal oncocytomas.
Simonnet H; Demont J; Pfeiffer K; Guenaneche L; Bouvier R; Brandt U; Schagger H; Godinot C
Carcinogenesis; 2003 Sep; 24(9):1461-6. PubMed ID: 12844484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
